Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adipose-derived Stem Cells for Diabetic Foot
NCT02831075Phase 1Unknown
- Start
- Jan 2015
- Primary completion
- Dec 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of adipose derived mesenchymal stromal cells in diabetic foot disease (DFD) and peripheral vascular disease (PVD) (2 arms). Primary endpoint: Area of diabetic foot ulcers at 3 months. Status: unknown.
02
Drugs
adipose derived mesenchymal stromal cells
03
Conditions
diabetic foot disease (DFD)peripheral vascular disease (PVD)
Beyond the preview
Go deeper on NCT02831075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02831075.